Ottawa invests more than $28 million to address PTSD and trauma in frontline and essential workers; the supercluster program gets a name change from Minister Champagne; patient-oriented research funding for Manitoba and Saskatchewan, Dr. Jody Cooley is appointed new ED at SNOLAB, and more.
Topic: Type 1 diabetes
The Short Report – Dec. 15, 2021: UBC launches diabetes centre of excellence, Standing Committees struck for 44th Parliament, exploring pandemic impacts, and more
Canada’s first JDRF Centre of Excellence in Type 1 diabetes research, science and technology standing committee members announced, Ottawa invests in pandemic research and vaccine confidence projects, and more.
Zucara Therapeutics secures funding for diabetes drug
Life sciences firm Zucara Therapeutics Inc. has secured non-dilutive funding of US$3.9 million for the pre-clinical advancement of its lead drug candidate for diabetes, ZT-01. Zucara’s partner, The Leona M. and Harry B. Helmsley Charitable Trust, will provide the funds in the form of a loan under a program-related investment (PRI). ZT-01 is focused on…